157 related articles for article (PubMed ID: 2118324)
1. Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.
Rustige C; Wiedemann B
Antimicrob Agents Chemother; 1990 Jun; 34(6):1107-11. PubMed ID: 2118324
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
Rossolini GM; Valentini S; Satta G
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and plasmid curing activity of lomefloxacin in vitro.
Derlot E; Poyart-Salmeron C; Courvalin P
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1048-52. PubMed ID: 2515963
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of lomefloxacin (NY-198 or SC 47111).
Shah PM; Müller S; Kipp J; Stille W
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506
[TBL] [Abstract][Full Text] [Related]
5. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
[TBL] [Abstract][Full Text] [Related]
6. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
Aldridge KE; Henderberg A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219
[TBL] [Abstract][Full Text] [Related]
7. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
Hoban D; Grabowski M; Koss J; Weselowski V
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of lomefloxacin.
Leigh DA; Tait S; Walsh B
J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
DiVincenzo CA; Shatzer KL; Venezio FR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
Wright DN; Saxon B; Matsen JM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
Sonstein SA; Dahlgren J
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
Qadri SM; Lee GC; Ellis ME
Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
Cornaglia G; Ligozzi M; Pelosi E; Canepari P; Fontana R
J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
[TBL] [Abstract][Full Text] [Related]
15. Postantibiotic effects of E-4868 and OPC-17116.
Sanford MD; Jones RN
J Antimicrob Chemother; 1993 Dec; 32(6):916-7. PubMed ID: 8144440
[No Abstract] [Full Text] [Related]
16. [In vitro antibacterial activity of cefpirome in combination with 4 aminoglycosides and 2 fluoroquinolones].
Le Noc P; Croize J; Bryskier A; Le Noc D
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):762-7. PubMed ID: 3141888
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
Stratton CW; Weeks LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):29S-34S. PubMed ID: 2791495
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
Leigh DA; Harris C; Tait S; Walsh B; Hancock P
J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
Torres JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
[TBL] [Abstract][Full Text] [Related]
20. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]